Feb 16, 2023 / 12:00PM GMT
Jonas Jarvius - Q-linea AB - CEO
Thank you very much for that. Also I would like to welcome everyone to our presentation for the last quarter of 2022. So I will start with showing our disclaimer slide in case me or Anders will make any forward-looking statements. Having read through that, I suggest we go into the highlights for the fourth quarter. I mean, you also know that we are working with development of disruptive solutions for faster infectious disease diagnostics and a first product targets sepsis.
It has been a very busy quarter and last year and also, we have incorporated a couple of events and news that came after the quarter end or period end. One of those news is that we have founded a subsidiary in the US as of December last year. And that also means now that Q-linea is a group of companies and we are, of course, working on a consolidated financial statement in accordance with IFRS. You can also see that we have decreased our number of employees and consultants a bit over the last quarter. And this is an overall process in moving into our new and updated business plan for this year
Q4 2022 Q linea AB Earnings Call Transcript
Mar 01, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers